Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Xeronine structure and function: computational comparative mastery of its mystery.

Sanni DM, Fatoki TH, Kolawole AO, Akinmoladun AC.

In Silico Pharmacol. 2017 Sep 2;5:8. doi: 10.1007/s40203-017-0028-y. eCollection 2017.

2.

Computational approaches to the in vitro antibacterial activity of Allium hirtifolium Boiss against gentamicin-resistant Escherichia coli: focus on ribosome recycling factor.

Ali SE, Chehri K, Karimi N, Karimi I.

In Silico Pharmacol. 2017 Aug 30;5:7. doi: 10.1007/s40203-017-0027-z. eCollection 2016.

3.

QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparum.

Qidwai T.

In Silico Pharmacol. 2016 Dec;5(1):6. doi: 10.1007/s40203-017-0026-0. Epub 2017 Jul 19.

4.

Molecular characterization, modeling, in silico analysis of equine pituitary gonadotropin alpha subunit and docking interaction studies with ganirelix.

Bhardwaj A, Nayan V, Sharma P, Kumar S, Pal Y, Singh J.

In Silico Pharmacol. 2016 Dec;5(1):5. doi: 10.1007/s40203-017-0025-1. Epub 2017 Jul 18.

5.

Molecular docking studies on thirteen fluoroquinolines with human topoisomerase II a and b.

Jadhav AK, Karuppayil SM.

In Silico Pharmacol. 2016 Dec;5(1):4. doi: 10.1007/s40203-017-0024-2. Epub 2017 Jun 30.

6.

Revealing the potency of Annona muricata leaves extract as FOXO1 inhibitor for diabetes mellitus treatment through computational study.

Damayanti DS, Utomo DH, Kusuma C.

In Silico Pharmacol. 2016 Dec;5(1):3. doi: 10.1007/s40203-017-0023-3. Epub 2017 Jun 26.

7.

In silico analysis of Shiga toxins (Stxs) to identify new potential vaccine targets for Shiga toxin-producing Escherichia coli.

Golshani M, Oloomi M, Bouzari S.

In Silico Pharmacol. 2016 Dec;5(1):2. doi: 10.1007/s40203-017-0022-4. Epub 2017 May 22.

8.

Study of intra-inter species protein-protein interactions for potential drug targets identification and subsequent drug design for Escherichia coli O104:H4 C277-11.

Mondal SI, Mahmud Z, Elahi M, Akter A, Jewel NA, Muzahidul Islam M, Ferdous S, Kikuchi T.

In Silico Pharmacol. 2016 Dec;5(1):1. doi: 10.1007/s40203-017-0021-5. Epub 2017 Apr 11.

9.

Classification model of amino acid sequences prone to aggregation of therapeutic proteins.

Marczak M, Okoniewska K, Grabowski T.

In Silico Pharmacol. 2016 Dec;4(1):6. doi: 10.1186/s40203-016-0019-4. Epub 2016 Jul 7.

10.

In silico proposition to predict cluster of B- and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni.

Yasmin T, Akter S, Debnath M, Ebihara A, Nakagawa T, Nabi AH.

In Silico Pharmacol. 2016 Dec;4(1):5. doi: 10.1186/s40203-016-0020-y. Epub 2016 Jul 4.

11.

A momentary biomarker for depressive mood.

Kim J, Nakamura T, Yamamoto Y.

In Silico Pharmacol. 2016 Dec;4(1):4. doi: 10.1186/s40203-016-0017-6. Epub 2016 Mar 16. Review.

12.

Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide.

Offman E, Phipps C, Edginton AN.

In Silico Pharmacol. 2016 Dec;4(1):3. doi: 10.1186/s40203-016-0018-5. Epub 2016 Mar 1.

14.

Determining optimal diagnostic criteria through chronicity and comorbidity.

Steinley D, Lane SP, Sher KJ.

In Silico Pharmacol. 2016 Dec;4(1):1. doi: 10.1186/s40203-016-0015-8. Epub 2016 Feb 1.

15.

Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.

Shilpi JA, Ali MT, Saha S, Hasan S, Gray AI, Seidel V.

In Silico Pharmacol. 2015 Dec;3(1):10. doi: 10.1186/s40203-015-0014-1. Epub 2015 Dec 8.

16.

In vitro cytotoxic and in silico activity of piperine isolated from Piper nigrum fruits Linn.

Paarakh PM, Sreeram DC, D SS, Ganapathy SP.

In Silico Pharmacol. 2015 Dec;3(1):9. doi: 10.1186/s40203-015-0013-2. Epub 2015 Oct 29.

17.

Computational modeling to predict the functions and impact of drug transporters.

Matsson P, Bergström CA.

In Silico Pharmacol. 2015 Dec;3(1):8. doi: 10.1186/s40203-015-0012-3. Epub 2015 Sep 4.

18.

Highly conserved regions in Ebola virus RNA dependent RNA polymerase may be act as a universal novel peptide vaccine target: a computational approach.

Oany AR, Sharmin T, Chowdhury AS, Jyoti TP, Hasan MA.

In Silico Pharmacol. 2015 Dec;3(1):7. doi: 10.1186/s40203-015-0011-4. Epub 2015 Aug 8.

19.

Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent.

El-Saadi MW, Williams-Hart T, Salvatore BA, Mahdavian E.

In Silico Pharmacol. 2015 Dec;3(1):6. doi: 10.1186/s40203-015-0010-5. Epub 2015 Jun 4.

20.

Supplemental Content

Loading ...
Support Center